Yoshihiro Otani
- Molecular Biology
- Oncology top 10%
- Genetics top 5%
- Radiology, Nuclear Medicine and Imaging top 10%
- Cancer Research
- Co-authors
- Isao DateKazuhiko KurozumiTomotsugu IchikawaBalveen KaurKyoji TsuchikamaWei XiongZhiqiang AnYasuaki Anami
- Topics
- Glioma Diagnosis and Treatment (29 papers)Virus-based gene therapy research (12 papers)Meningioma and schwannoma management (8 papers)
- Journals
- Nature CommunicationsSHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Yoshihiro Otani
57 papers receiving 844 citations
Hit Papers
Peers
Comparison fields: 5 of 77
- Molecular Biology 373
- Oncology 329
- Genetics 200
- Radiology, Nuclear Medicine and Imaging 186
- Cancer Research 119
Countries citing papers authored by Yoshihiro Otani
This map shows the geographic impact of Yoshihiro Otani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshihiro Otani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshihiro Otani more than expected).
Fields of papers citing papers by Yoshihiro Otani
This network shows the impact of papers produced by Yoshihiro Otani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshihiro Otani. The network helps show where Yoshihiro Otani may publish in the future.
Co-authorship network of co-authors of Yoshihiro Otani
This figure shows the co-authorship network connecting the top 25 collaborators of Yoshihiro Otani. A scholar is included among the top collaborators of Yoshihiro Otani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshihiro Otani. Yoshihiro Otani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 2 | |
| 7 | 0 | |
| 8 | 2 | |
| 9 | 6 | |
| 10 | 3 | |
| 11 | 3 | |
| 12 | 12 | |
| 13 | Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistancebreakdown → | 210 |
| 14 | 14 | |
| 15 | 70 | |
| 16 | 25 | |
| 17 | 27 | |
| 18 | 15 | |
| 19 | 12 | |
| 20 | 14 |
About Yoshihiro Otani
Yoshihiro Otani is a scholar working on Genetics, Neurology and Cancer Research, having authored 65 papers that have together received 853 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (29 papers), Virus-based gene therapy research (12 papers) and Meningioma and schwannoma management (8 papers). The work is most often cited by research in Genetics (200 citations), Oncology (329 citations) and Radiology, Nuclear Medicine and Imaging (186 citations). Yoshihiro Otani has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Isao Date, Kazuhiko Kurozumi, Tomotsugu Ichikawa, Balveen Kaur, Kyoji Tsuchikama, Wei Xiong, Zhiqiang An, Yasuaki Anami, Ningyan Zhang and Aiko Yamaguchi. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.